Tykerb

Active Ingredient(s): Lapatinib
FDA Approved: * March 13, 2007
Pharm Company: * GLAXOSMITHKLINE
Category: Cancer

Lapatinib (INN), used in the form of lapatinib ditosylate (USAN) (trade names Tykerb and Tyverb marketed by Novartis) is an orally active drug for breast cancer and other solid tumours.[1] It is a dual tyrosine kinase inhibitor which interrupts the HER2/neu and epidermal growth factor receptor (EGFR) pathways.[2] It is used in combination therapy for HER2-positive breast cancer. It is used for the treatment of patients with advanced or metastatic breast cancer ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Tykerb GS;XJG
Tykerb 250 mg Oral Tablet
NDC: 0173-0752
Labeler:
Glaxosmithkline LLC
Tykerb GS;XJG
Tykerb 250 mg Oral Tablet
NDC: 0078-0671
Labeler:
Novartis Pharmaceuticals Corporation

Popular Topics

Tykerb=Tyverb Europe liver

Hi, Sorry for my English but as the knowledge of this medicin is more advanced in the United States, I prefer ask my que...

1 REPLY